JASPER THERAPEUTICS, INC. Shareholders' Equity
JASPER THERAPEUTICS, INC. (JSPR) had Shareholders' Equity of $1.41 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.41M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.40M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $4.15M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $11.57M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.41M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.40M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $4.15M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $11.57M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $23.50M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $42.24M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $61.67M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $83.68M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $100.31M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $113.23M 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $78.44M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $94.13M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $110.20M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $125.20M 10-Q · filed 2024-08-13 | |
| 2022-12-31 | $35.99M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $47.56M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $58.78M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $68.11M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $69.52M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $78.60M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$52.60M 10-Q · filed 2022-11-10 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$44.55M 10-Q · filed 2022-11-10 | $5.00M 10-Q · filed 2021-05-24 |
| 2020-12-31 | -$35.13M 10-K · filed 2023-03-08 | $5.00M 10-K · filed 2021-03-30 |
| 2020-09-30 | -$25.64M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$15.13M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$6.17M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$4.73M 10-K · filed 2022-03-18 | $5.00M 10-K · filed 2020-03-26 |
| 2019-09-30 | $24.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |